BroadOak Capital Partners, based in Maryland, backs life sciences companies, can lead rounds, and has added over $200 million in permanent capital to its platform.
10 people on the investing team, 7 of them partners who can make the call. Partners are listed first.










Work here and something is wrong? Ask for a correction.


Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
BroadOak Capital Partners has not reported an entry stage.
BroadOak Capital Partners has not reported a check size.
Yes. BroadOak Capital Partners says it can lead.
Austin Duke (Managing Director), Daniel Friedman (Managing Director), Michael Caspani (Managing Director), Bill Snider (Partner), Lars Hanan (Partner), Matt McFarland (Partner).
No recent activity since September 2026.
Work at BroadOak Capital Partners? Claim or correct this profile.